• Gilead mulls repositioning failed Ebola drug in China virus 

    23 days ago - By Fierce Biotech

    Gilead is considering repositioning NUC inhibitor remdesivir as a treatment for the coronavirus now sweeping across parts of China. The antiviral last made headlines when Gilead tested it, with little success, as a treatment for Ebola virus.
    Read more ...